MATERNUS-Kliniken AG (DE:MAK)
XETRA:MAK
Want to see DE:MAK full AI Analyst Report?
Total Valuation
MATERNUS-Kliniken AG has a market cap or net worth of €19.71M. The enterprise value is €199.25M.
Market Cap€19.71M
Enterprise Value€199.25M
Share Statistics
MATERNUS-Kliniken AG has 20,970,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding20,970,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
MATERNUS-Kliniken AG’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is -4.75%.
Return on Equity (ROE)0.17
Return on Assets (ROA)-0.09
Return on Invested Capital (ROIC)-4.75%
Return on Capital Employed (ROCE)-0.11
Revenue Per Employee81.27K
Profits Per Employee-8.79K
Employee Count1,452
Asset Turnover0.79
Inventory Turnover232.84
Valuation Ratios
The current PE Ratio of MATERNUS-Kliniken AG is ―. MATERNUS-Kliniken AG’s PEG ratio is -0.32.
PE Ratio―
PS Ratio0.18
PB Ratio-0.27
Price to Fair Value-0.27
Price to FCF1.92
Price to Operating Cash Flow1.96
PEG Ratio-0.32
Income Statement
In the last 12 months, MATERNUS-Kliniken AG had revenue of 118.00M and earned -13.90M in profits. Earnings per share was -0.66.
Revenue118.00M
Gross Profit23.00M
Operating Income-6.12M
Pretax Income-12.76M
Net Income-13.90M
EBITDA4.08M
Earnings Per Share (EPS)-0.66
Cash Flow
In the last 12 months, operating cash flow was 9.84M and capital expenditures -95.00K, giving a free cash flow of 9.74M billion.
Operating Cash Flow9.84M
Free Cash Flow9.74M
Free Cash Flow per Share0.46
Dividends & Yields
MATERNUS-Kliniken AG pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.59
52-Week Price Change-36.99%
50-Day Moving Average1.01
200-Day Moving Average1.05
Relative Strength Index (RSI)47.88
Average Volume (3m)618.00
Important Dates
MATERNUS-Kliniken AG upcoming earnings date is Aug 20, 2026, TBA (Confirmed).
Last Earnings DateApr 30, 2026
Next Earnings DateAug 20, 2026
Ex-Dividend Date―
Financial Position
MATERNUS-Kliniken AG as a current ratio of 0.21, with Debt / Equity ratio of -227.32%
Current Ratio0.21
Quick Ratio0.20
Debt to Market Cap5.74
Net Debt to EBITDA44.01
Interest Coverage Ratio-0.76
Taxes
In the past 12 months, MATERNUS-Kliniken AG has paid 1.09M in taxes.
Income Tax1.09M
Effective Tax Rate-0.09
Enterprise Valuation
MATERNUS-Kliniken AG EV to EBITDA ratio is 49.25, with an EV/FCF ratio of 17.98.
EV to Sales1.70
EV to EBITDA49.25
EV to Free Cash Flow17.98
EV to Operating Cash Flow14.31
Balance Sheet
MATERNUS-Kliniken AG has €2.18M in cash and marketable securities with €186.99M in debt, giving a net cash position of -€184.81M billion.
Cash & Marketable Securities€2.18M
Total Debt€186.99M
Net Cash-€184.81M
Net Cash Per Share-€8.81
Tangible Book Value Per Share-€4.47
Margins
Gross margin is 25.02%, with operating margin of -5.18%, and net profit margin of -11.78%.
Gross Margin25.02%
Operating Margin-5.18%
Pretax Margin-10.81%
Net Profit Margin-11.78%
EBITDA Margin3.45%
EBIT Margin-4.02%
Analyst Forecast
The average price target for MATERNUS-Kliniken AG is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast3.51%
EPS Growth Forecast-5.66%